Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease

Abstract Background The influence of aldosterone breakthrough (ABT) on proteinuria reduction during renin‐angiotensin system (RAS) inhibition for spontaneous proteinuric chronic kidney disease (CKDP) has not been determined in dogs. Objectives Determine whether ABT occurs in dogs with CKDP and if it...

Full description

Bibliographic Details
Main Authors:	Marisa K. Ames, Shelly L. Vaden, Clarke E. Atkins, Jean‐Sebastien Palerme, Catherine E. Langston, Gregory F. Grauer, Sarah Shropshire, Christina Bove, Tracy Webb
Format:	Article
Language:	English
Published:	Wiley 2022-11-01
Series:	Journal of Veterinary Internal Medicine
Subjects:	mineralocorticoid receptor antagonists nephrology renin‐angiotensin‐aldosterone system urine aldosterone to creatinine ratio
Online Access:	https://doi.org/10.1111/jvim.16573

Similar Items

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Advances in Unraveling the Role of the Renin-Angiotensin-AldosteroneSystem in Osteoporosis Pathogenesis
by: Zige Liu, et al.
Published: (2024-01-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

THE CORRELATION BETWEEN THE RENIN AT ALDOSTERONE SYSTEM – ARTERIAL HYPERTENSION AND HORMONAL MECHANISMS
by: Liviu Stafie, et al.
Published: (2024-09-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
by: Seung-Hwa Lee, et al.
Published: (2022-01-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

Immune Optimization as a Preventive and Therapeutic Adjunct for the Management of Renin–Angiotensin–Aldosterone System Dysfunction Diseases: A Review
by: Michael T. Okafor, et al.
Published: (2024-07-01)

Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum
by: Dana Pop, et al.
Published: (2024-07-01)

Low plasma renin activity is associated with “Apparently” idiopathic atrial fibrillation
by: Youmei Shen, et al.
Published: (2023-12-01)

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?
by: Juan José García Martínez, et al.
Published: (2022-11-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

Assessment of Parathyroid Hormone, Vitamin D, Calcium, and Renin-angiotensin-aldosterone System in Nigerians With Hypertension
by: Oloruntoba Ayodele Ekun, et al.
Published: (2024-08-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)

Role of renin–angiotensin aldosterone system on short-term blood pressure variability in hypertensive patients
by: Minako Inoue, et al.
Published: (2018-10-01)

A New Perspective on the Renin-Angiotensin System
by: Adrian Martyniak, et al.
Published: (2022-12-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
by: Stepan Gambaryan, et al.
Published: (2023-08-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Hyperkalemia: A Cause of Non-adherence to Renin- Angiotensin-Aldosterone System Inhibitors in Chronic Kidney Disease: A Retrospective Study
by: Sibel Gülçiçek, et al.
Published: (2023-11-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Gestational Geophagia Affects Nephrocardiac Integrity, ATP-Driven Proton Pumps, the Renin–Angiotensin–Aldosterone System, and F2-Isoprostane Status
by: Emmanuel Nnabugwu Agomuo, et al.
Published: (2019-01-01)

A traditional Korean fermented food, Gochujang exerts anti-hypertensive effects, regardless of its high salt content by regulating renin-angiotensin-aldosterone system in SD rats
by: Jung Eun Park, et al.
Published: (2024-05-01)

Regulation of human salt-sensitivite hypertension by myeloid cell renin-angiotensin-aldosterone system
by: Lale A. Ertuglu, et al.
Published: (2023-07-01)

Cutoff Values of Aldosterone and the Aldosterone–Renin Ratio for Predicting Primary Aldosteronism in Patients with Resistant Hypertension: A Real-Life Study
by: João Vicente da Silveira, et al.
Published: (2024-09-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

Characterization of the circulating markers of the renin‐angiotensin‐aldosterone system in telmisartan‐ or enalapril‐treated dogs with proteinuric chronic kidney disease
by: Joanna E. Murdoch, et al.
Published: (2024-09-01)

Poor Performance of Angiotensin II Enzyme-Linked Immuno-Sorbent Assays in Mostly Hypertensive Cohort Routinely Screened for Primary Aldosteronism
by: Agnieszka Łebek-Szatańska, et al.
Published: (2022-04-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

Angiotensin-converting-enzyme gene insertion-deletion polymorphism and renin angiotensin aldosterone system activity in different phenotypes of polycystic ovary syndrome
by: Khansa Chaabouni, et al.
Published: (2024-11-01)

Renin–angiotensin–aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study
by: Katharina Krenn, et al.
Published: (2025-01-01)

Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism
by: Lukas Engler, et al.
Published: (2019-04-01)